List of insiders holdings for Astria Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director |
2024-11-14 16:41:28 | 6,485,420 0 |
6,485,420 | Form 13D |
| 2 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner |
2024-11-14 16:41:28 | 6,485,420 0 |
6,485,420 | Form 13D |
| 3 | SVLSF V LLC SV Life Sciences Fund V (GP) LP SV LIFE SCIENCES FUND V LP SV Life Sciences Fund V Strategic Partners L.P. 10% Owner |
2017-02-07 06:11:32 | 2,857,667 0 |
2,857,667 | Form 13D |
| 4 | Clarus Lifesciences II L.P. Clarus Ventures II GP L.P. Clarus Ventures II LLC 10% Owner |
2018-04-04 16:42:28 | 2,024,783 0 |
2,024,783 | Form 13D |
| 5 | Laufer Ron Director 10% Owner |
2015-06-30 18:45:19 | 11,094 1,632,652 |
1,643,746 | Form 4 |
| 6 | MedImmune Ventures Inc. 10% Owner |
2015-06-30 18:45:33 | 1,632,652 0 |
1,632,652 | Form 4 |
| 7 | Advanced Technology Ventures VIII LP ATV Associates VIII L.L.C. 10% Owner |
2018-02-14 15:33:14 | 1,133,943 0 |
1,133,943 | Form 13G |
| 8 | Milne Jill C. CEO and President |
2025-03-25 16:07:38 | 761,000 0 |
761,000 | Form 4 |
| 9 | Matthews Andrea Chief Business Officer |
2025-03-25 16:07:11 | 262,500 0 |
262,500 | Form 4 |
| 10 | Harshbarger Benjamin Chief Legal Officer |
2025-03-25 16:06:17 | 262,500 0 |
262,500 | Form 4 |
| 11 | Clauser Noah Chief Financial Officer |
2025-03-25 16:05:43 | 262,500 0 |
262,500 | Form 4 |
| 12 | Morabito Christopher Chief Medical Officer |
2025-03-25 16:05:11 | 262,500 0 |
262,500 | Form 4 |
| 13 | Jirousek Michael Chief Scientific Officer |
2015-06-30 18:48:03 | 246,093 0 |
246,093 | Form 4 |
| 14 | Komjathy Andrew Chief Commercial Officer |
2025-03-25 16:06:49 | 225,000 0 |
225,000 | Form 4 |
| 15 | Hibben Edward K. Chief Business Officer |
2018-02-09 16:01:34 | 100,000 0 |
100,000 | Form 4 |
| 16 | Donovan Joanne M. CMO; SVP Clinical Development |
2020-02-14 15:00:22 | 60,000 0 |
60,000 | Form 4 |
| 17 | Nichols Andrew John Chief Scientific Officer |
2022-03-03 19:18:58 | 55,000 0 |
55,000 | Form 4 |
| 18 | Sanderson Ian C. Chief Financial Officer |
2016-02-16 18:27:42 | 52,000 0 |
52,000 | Form 4 |
| 19 | Modi Rick Chief Business Officer |
2016-09-13 17:24:54 | 45,000 0 |
45,000 | Form 4/A |
| 20 | Cunnane Deirdre A. Chief Legal Officer |
2019-02-15 08:42:34 | 40,000 0 |
40,000 | Form 4 |
| 21 | AGARWAL SUNIL Director |
2024-04-09 08:11:28 | 28,200 0 |
28,200 | Form 4 |
| 22 | BATE KENNETH Director |
2024-06-06 16:05:11 | 14,100 0 |
14,100 | Form 4 |
| 23 | Cole Hugh M Director |
2024-06-06 16:05:40 | 14,100 0 |
14,100 | Form 4 |
| 24 | KISHBAUCH MICHAEL D Director |
2024-06-06 16:06:13 | 14,100 0 |
14,100 | Form 4 |
| 25 | Callori Fred Director |
2024-06-06 16:06:36 | 14,100 0 |
14,100 | Form 4 |
| 26 | Violin Jonathan Director |
2024-06-06 16:06:56 | 14,100 0 |
14,100 | Form 4 |
| 27 | Beck Joanne T. Director |
2024-06-06 16:07:20 | 14,100 0 |
14,100 | Form 4 |
| 28 | LAPOINTE ANTHONY GREGG Director |
2024-06-06 16:07:49 | 14,100 0 |
14,100 | Form 4 |
| 29 | Ross Michael Jay Director |
2018-06-07 18:19:58 | 14,000 0 |
14,000 | Form 4 |
| 30 | George Jean Director |
2018-06-07 18:04:23 | 14,000 0 |
14,000 | Form 4 |
| 31 | ADELMAN BURT A Director |
2020-06-12 11:44:42 | 7,500 0 |
7,500 | Form 4 |
| 32 | GALAKATOS NICHOLAS Director |
2016-08-05 16:09:12 | 6,500 0 |
6,500 | Form 4 |